Related Experiment Videos
[Fatal outcome after overdosage with antidepressants]
Martin Faurholdt Gude1, Lisbet Tokkesdal Jensen, Lars Bjerre-Kristensen
1Lungemedicinsk Afdeling, Aarhus Universitetshospital, Nørrebrogade 44, 8000 Aarhus C. larskris@rm.dk.
Ugeskrift for Laeger
|October 28, 2014
Summary
Serotonin syndrome (SS) can be fatal, especially with selective serotonin reuptake inhibitors (SSRI) and selective noradrenaline reuptake inhibitors (SNRI) overdoses. Prompt recognition of SS symptoms in emergency departments is crucial for patient outcomes.
Area of Science:
- Pharmacology
- Clinical Toxicology
Background:
- Serotonin syndrome (SS) is a potentially life-threatening condition resulting from excessive serotonergic activity.
- It is commonly associated with antidepressant overdoses, particularly selective serotonin reuptake inhibitors (SSRIs) and selective noradrenaline reuptake inhibitors (SNRIs).
Observation:
- This case report details a 54-year-old male who rapidly developed SS symptoms after ingesting 6.5 g of SSRI and SNRI medications.
- The patient's presentation highlights the severe consequences of significant antidepressant overdoses.
Findings:
- The rapid onset of symptoms underscores the acute toxicity of high-dose SSRI/SNRI ingestion.
- This case demonstrates that severe SS can occur even when these agents are the sole drug types involved.
Implications:
- Clinicians must maintain a high index of suspicion for SS in patients presenting with relevant symptoms after antidepressant exposure.
- Early recognition and management in emergency settings are critical for improving patient prognosis and preventing fatal outcomes.